Dr Kummar is Professor of Medicine and Director of the Phase I Clinical Research and Translational Oncology Programs at Stanford University. Prior to joining Stanford in 2015, Dr Kummar served as the Head of Early Clinical Trials Development in the Office of the Director, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA. Her research interests focus on developing novel therapies for cancer, conducting pharmacokinetic- and pharmacodynamic-driven first-in-human trials. The clinical studies integrate genomics, imaging and laboratory correlates into early phase trials. She serves on multiple national and international scientific committees and has published >125 papers in peer-reviewed journals.
Press return to search